Ajinomoto Of Japan To Merge Units To Make More Innovative Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's Ajinomoto plans to merge two of its subsidiaries as of April 1 to coincide with a new program intended to reduce the price of drugs that have lost patent protection